CleanSpace (ASX:CSX): AGILE Respirator Certification Supports Industrial Growth Strategy

Sonal Goyal

18 September 2026 04:01 PM AEST

CleanSpace (ASX:CSX): AGILE Respirator Certification Supports Industrial Growth Strategy

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Highlights

CleanSpace (ASX:CSX) develops powered air-purifying respirators for healthcare and industrial users.
The AGILE respirator has achieved certification across key markets.
The company is expanding beyond healthcare into industrial safety applications.
Commercial adoption, customer conversion and profitability remain key areas to monitor.

CleanSpace Holdings Limited (ASX:CSX) designs and develops powered air-purifying respirators that provide filtered breathing protection across healthcare and industrial environments. The company’s AGILE product represents an expansion of its respiratory protection portfolio, targeting industries where lightweight and comfortable protective equipment is required.

AGILE Respirator and Certification Progress

CleanSpace AGILE is a powered air-purifying respirator designed for industrial environments where workers may face dust or hazardous airborne particles. The product uses battery-powered airflow technology to provide filtered air without relying on conventional tight-fitting masks.

The company announced that AGILE achieved certification under Australian and New Zealand respiratory protection standards and had also received European certification. These approvals support commercial availability across selected markets.

Expanding Beyond Healthcare

CleanSpace historically built its Business around respiratory protection solutions for healthcare environments. The company is now expanding into industrial sectors including mining, construction and manufacturing.

Moving into industrial markets provides an opportunity to diversify customer demand, although success depends on customer adoption, distribution capability and competition within respiratory protection markets.

Commercial Opportunity and Market Factors

The AGILE product is designed around portability and user comfort. Its loose-fitting design may address situations where traditional tight-fitting respirators are unsuitable for some workers.

However, certification represents the beginning of commercialisation rather than guaranteed adoption. Industrial customers often require extensive evaluation processes before changing established safety equipment suppliers.

Key Considerations for Future Growth

CleanSpace will need to demonstrate that AGILE can translate regulatory approvals into commercial orders. The company must manage manufacturing, inventory requirements and customer support while continuing to develop its respiratory technology portfolio.

Key Insights

CleanSpace is using its respiratory technology platform to expand from healthcare applications into industrial safety markets. The AGILE certification provides a pathway for broader commercial activity, while future progress depends on customer uptake, execution and sustainable Revenue growth.

FAQs

Q: What does CleanSpace develop?

A:CleanSpace develops powered air-purifying respirators for healthcare and industrial applications.

Q: What is the AGILE respirator?

A:AGILE is a powered respirator designed to provide filtered breathing protection in industrial environments.

Q: Why is certification important?

A:Certification allows the product to be sold in approved markets and supports commercial expansion.

Q: What factors may influence CleanSpace’s progress?

A:Customer adoption, market competition and commercial execution are key factors.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.